According to the Society of Neuroscience, the average human brain has about 90 billion neurons that make 100 trillion connections or synapses. Scientists believe this astounding number of neurons is accountable for the traits that make us uniquely human: our thoughts, memories and emotions. Recent technological advances have made the brain accessible in a way that previous generations of scientists could only dream about. And yet the brain is still a mystery. On this episode of Innovation Unleashed, we will talk with Dr. Donald Whiting, Chair of the Department of Neurosurgery for Allegheny Health Network and is Director of the Allegheny General Hospital’s nationally recognized Center for Spasticity and Movement Disorders and Division of Neuromodulation and one of just a handful of renowned specialists in the country who are helping study and pioneer the use of Deep Brain Stimulation for treating conditions other than movement disorders, including obesity and obsessive compulsive disorder. Dr. Whiting will also discuss novel techniques and technologies to better image the spine and provide more personalized care strategies for patients with back and neck injuries.
In this week’s episode, Lynn Banaszak continues her conversations with world leaders about improving patient outcomes, enhancing wellness of healthy consumers, exploring digital therapeutics and new care delivery tools. While on location at the Health XL Global Gathering, she talked with Dr. David Levine, a general internist and research fellow in the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital and Harvard Medical School about his Home Hospital research. Instead of admitting patients to the hospital, he “admits” them back home. He also shares some of his other interests in the quality of outpatient care, digital health tech and novel approaches of care delivery.
In this week’s episode Innovation Unleashed heads back to the Health XL Global Gathering to talk with world leaders about improving patient outcomes, enhancing wellness of healthy consumers, driving R&D operational advances, and exploring digital therapeutics and genomics. Alexander Grunewald, Global Head of HealthTech Business Development at Johnson & Johnson shares his perspective about innovation being the lifeblood in pharma and the way that patient outcomes lead all of their efforts to bring the right healthcare solutions to market.
The business of innovation requires leaders that understand that new ideas and implementation of those ideas can’t end and begin with them. They understand that they must bring others along on the journey, helping to get them to think in new ways. They understand that they must invest in ideas and take risk. By doing so, they can build an entire movement and ecosystem of forward-thinkers and innovative ideas. Dr. Alan Russell and Lynn Banaszak have been working to create an ecosystem of innovation for decades. Let’s listen as they discuss their path to innovation.